About
Dr Edward Routledge is a researcher at Newcastle University with a 26-year publication record (1988-2014) specializing in virology and immunology. His work centers on respiratory viruses, particularly respiratory syncytial virus (RSV) and influenza A, with significant contributions to understanding viral glycoprotein functions, antibody engineering, and mechanisms of viral entry and immune response.
His research focuses on molecular interactions between viruses and host immune systems, specifically investigating RSV G glycoprotein epitopes, influenza haemagglutinin-mediated membrane fusion, and engineered antibody therapeutics. Key areas include monoclonal antibody development for viral neutralization, viral protein purification techniques, and animal model validation of protective immune responses, with direct implications for vaccine design and antiviral strategies against respiratory pathogens.
Publication analysis reveals an evolution from foundational protein characterization in the 1980s-1990s toward sophisticated antibody engineering and epitope mapping in the 2000s. His work consistently addresses translational challenges in viral pathogenesis, demonstrating strong continuity in RSV research while expanding into influenza mechanisms, with all studies emphasizing practical applications for infection prevention and treatment.
Research fields
